Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Uchsc Anschultz Cancer Pavilion

Neither a doctor nor a teaching hospital

Research payments

$811,309

14 payments

Through program year 2025, Uchsc Anschultz Cancer Pavilion is reported as receiving $811,309 in research payments, across 14 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $650,000 1
2024 Research $161,309 13

Breakdown

Who paid Research payments · program years 2024–2025
  1. AbbVie, Inc. $811,309 14 payments
Studies the money was for Research payments · program years 2024–2025
  1. A phase II evaluation of maintenance therapy combination Mirvetuximab Soravtansine and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer $650,000 1 payment
  2. First in Human Study of IMGN151 in Recurrent Gynaecological Cancers $155,324 9 payments
  3. M21-471 Ph2b PoC Study (2068-201-008) $3,728 1 payment
  4. M20-098 ABBV-951 aPD $1,057 1 payment
  5. M21-404 ABBV-400 Ph1 FIH Advanced Solid Tumors $600 1 payment
  6. M15-737 ABBV-951 Ph 3 Open Label Extension Study (Ind 1) $600 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record